 | AC Immune SA | |||
| NGM : ACIU || Location: Switzerland | ||||
$2.46+0.04 (+1.65%) |
0.01 M | 2.43 - 2.51 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.561 M |
| March 15, 2024 | 0.583 M |
| Feb. 29, 2024 | 0.628 M |
| Feb. 15, 2024 | 0.668 M |
| Jan. 31, 2024 | 0.481 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.12 | -0.05 | 56.75% |
| 09/30/2023 | 0.03 | -0.18 | -787.02% |
| 06/30/2023 | -0.20 | -0.20 | 0.65% |
| 03/31/2023 | -0.23 | -0.21 | 10.29% |
| 12/31/2022 | -0.26 | -0.23 | 10.54% |
ACIU Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 98.899M | Shares Float | 39.636M |
| Short Float | 0.561M | Market Cap | 239.34M |
| Institution ownership | 30.23% | Insider ownership | 41.872% |
| Earnings Date | 04/25/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.70 | Forward EPS | -0.23 |